These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33976000)

  • 21. Acute liver injury after intravenous amiodarone: a case report.
    Verhovez A; Elia F; Riva A; Ferrari G; Aprà F
    Am J Emerg Med; 2011 Sep; 29(7):843.e5-6. PubMed ID: 20870371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
    Connolly SJ; Gent M; Roberts RS; Dorian P; Roy D; Sheldon RS; Mitchell LB; Green MS; Klein GJ; O'Brien B
    Circulation; 2000 Mar; 101(11):1297-302. PubMed ID: 10725290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe acute hepatitis following intravenous amiodarone : a case report and review of the literature.
    Stratton A; Fenderson J; Kenny P; Helman DL
    Acta Gastroenterol Belg; 2015 Jun; 78(2):233-9. PubMed ID: 26151694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute hepatotoxicity from intravenous amiodarone in a patient on hemodialysis].
    Bucco S; Arazzi M; Giunta F; Grabocka X; Longo MO; Silvestri S; Spetrino N; Tondo M; Vigilante G; Bonomini M
    G Ital Nefrol; 2016; 33(1):. PubMed ID: 26913742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatotoxicity after intravenous amiodarone.
    Cataldi A; Gonella D; Robutti N; Siri M; Buonocore S; Odetti P
    Aging Clin Exp Res; 2008 Dec; 20(6):593-6. PubMed ID: 19179845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
    Fogel RI; Herre JM; Kopelman HA; Kowey PR; Trohman RG; Fineberg N; Prystowsky EN
    Am Heart J; 2000 Apr; 139(4):690-5. PubMed ID: 10740153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute hepatitis induced by parenteral amiodarone.
    Gregory SA; Webster JB; Chapman GD
    Am J Med; 2002 Aug; 113(3):254-5. PubMed ID: 12208392
    [No Abstract]   [Full Text] [Related]  

  • 28. Amiodarone: clinical trials.
    Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
    Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amiodarone-induced liver dysfunctions].
    Gassanov N; Caglayan E; Erdmann E; Er F
    Dtsch Med Wochenschr; 2010 Jul; 135(27):1372-4. PubMed ID: 20589584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator.
    Gao D; Van Herendael H; Alshengeiti L; Dorian P; Mangat I; Korley V; Ahmad K; Golovchiner G; Aves T; Pinter A
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):199-204. PubMed ID: 23609328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication.
    Tsai CL; Chang WT; Weng TI; Fang CC; Walson PD
    Clin Ther; 2005 Mar; 27(3):336-41. PubMed ID: 15878387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D; Breithardt G
    Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current role of amiodarone in antiarrhythmic therapy].
    Sohns C; Zabel M
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):239-43. PubMed ID: 21104260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy.
    Matsuyama T; Tanno K; Kobayashi Y; Obara C; Ryu S; Adachi T; Ezumi H; Asano T; Miyata A; Koba S; Baba T; Katagiri T
    Jpn Circ J; 2001 May; 65(5):468-70. PubMed ID: 11348056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous amiodarone: offender or bystander?
    Guglin M
    Crit Care Med; 2005 Jan; 33(1):245-6. PubMed ID: 15644685
    [No Abstract]   [Full Text] [Related]  

  • 37. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias.
    Zivin A; Bardy GH
    Am J Cardiol; 1999 Nov; 84(9A):63R-68R. PubMed ID: 10568662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of N-Acetylcysteine for Clozapine-Induced Acute Liver Injury: A Case Report and Literature Review.
    Shah J; Muir J; Furfaro D; Beitler JR; Dzierba AL
    J Pharm Pract; 2023 Apr; 36(2):463-467. PubMed ID: 34284670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.